The growing popularity of cannabidiol (CBD) raises many questions about its regulation and support by health organizations. Does Social Security cover the purchase of CBD products? Let's see this in detail.
What is CBD?
CBD is one of several cannabinoids found in cannabis. Unlike THC , CBD does not have a psychotropic effect, but it is known for its soothing and anti-inflammatory properties. Numerous studies suggest that CBD could help in the treatment of certain illnesses such as epilepsy, anxiety and chronic pain.
CBD and social security
In France, social security covers certain prescription medications that contain cannabis or cannabis derivatives. However, this support is limited to specific medical conditions and certain medications.
Currently, the majority of CBD-based products sold as food supplements or wellness products are not covered by social security. This means that if you purchase CBD oil, capsules, or other forms of CBD for wellness purposes, you will not receive a refund.
Why this lack of support?
The regulations surrounding cannabis and its derivatives are complex. As CBD is still a subject of research, all its effects and medical applications are not yet fully known. Furthermore, the distinction between medical use and well-being makes it difficult to establish systematic reimbursement.
Could the situation change?
As the scientific world continues to study the potential of CBD, it is possible that in the future other forms of CBD or new therapeutic applications will be supported. However, for now, if you want to reap the benefits of CBD, you generally have to finance it out of your own pocket.
Conclusion
CBD has many potential health benefits, but its purchase as a wellness product is currently not supported by Social Security. It is therefore essential to be well informed before any purchase and to remain attentive to regulatory developments.
Do not hesitate to visit our store to discover our CBD oils produced from organic CBD flowers grown with passion while respecting nature.
References :
- Iffland K, Grotenhermen F. “An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies.” Cannabis Cannabinoid Res. 2017. Accessed on PubMed
- “Cannabidiol (CBD) Pre-Review Report.” World Health Organization. 2017. Consulted on the WHO website
- “Medicines based on cannabis or its derivatives”. Social Security. Consulted on the Health Insurance website